BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gavriilaki M, Moschou M, Papaliagkas V, Notas K, Chatzikyriakou E, Zafeiridou G, Papagiannopoulos S, Arnaoutoglou M, Kimiskidis VK. Biomarkers of disease progression in adolescents and adults with 5q spinal muscular atrophy: a systematic review and meta-analysis. Neuromuscular Disorders 2022. [DOI: 10.1016/j.nmd.2021.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gavriilaki M, Papaliagkas V, Stamperna A, Moschou M, Notas K, Papagiannopoulos S, Arnaoutoglou M, Kimiskidis VK. Biomarkers of therapeutic efficacy in adolescents and adults with 5q spinal muscular atrophy: a systematic review. Acta Neurol Belg 2022. [PMID: 35861914 DOI: 10.1007/s13760-022-02028-6] [Reference Citation Analysis]
2 Gavriilaki M, Moschou M, Papaliagkas V, Notas K, Chatzikyriakou E, Papagiannopoulos S, Arnaoutoglou M, Kimiskidis VK. Nusinersen in Adults with 5q Spinal Muscular Atrophy: a Systematic Review and Meta-analysis. Neurotherapeutics 2022. [PMID: 35178673 DOI: 10.1007/s13311-022-01200-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 De Wel B, De Schaepdryver M, Poesen K, Claeys KG. Biochemical and clinical biomarkers in adult SMA 3-4 patients treated with nusinersen for 22 months. Ann Clin Transl Neurol 2022. [PMID: 35833245 DOI: 10.1002/acn3.51625] [Reference Citation Analysis]